Therapeutic effects of fractionated radioimmunotherapy (RAIT) with clivatuzumab tetraxetan combined with low-dose gemcitabine (Gem) in advanced pancreatic cancer (APC) Conference

Ocean, AJ, Guarino, MJ, Pennington, KL et al. (2010). Therapeutic effects of fractionated radioimmunotherapy (RAIT) with clivatuzumab tetraxetan combined with low-dose gemcitabine (Gem) in advanced pancreatic cancer (APC) . JOURNAL OF CLINICAL ONCOLOGY, 28(15), 10.1200/jco.2010.28.15_suppl.4115

cited authors

  • Ocean, AJ; Guarino, MJ; Pennington, KL; O'Neil, BH; Lima, CS Rocha; Bekali-Saab, TS; Gulec, SA; Gold, DV; Wegener, WA; Goldenberg, DM

sustainable development goals

authors

publication date

  • May 20, 2010

webpage

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • AMER SOC CLINICAL ONCOLOGY

volume

  • 28

issue

  • 15